I won't say that ZGNX is recession / risk-off proof, but people who have chronic pain, who use opioids, who need a drug without acetaminophen, will simply ask for this drug. And, their doctors will be hard pressed to find a good reason not to Rx. The smear campaign, fear mongering, Mylan wailing, drum beating, hysteria provoking nay-sayers won't budge the needle on reversing FDA's approval of Zohydro. I have no doubt that patients will sign a waiver, acknowledging that they fully understand the risks of breaking open capsules and taking the meds in any other manner than which they are intended. ZGNX should be a double from here in 6 months; baring some major market melt-down. And then there's Relday! Oh, and thanks to CNBC for their great exposure; what a gift.